Guggenheim initiates Scribe Therapeutics stock with buy rating
2 sources
·1h ago
← All stories
Scribe Therapeutics
Biological Products, (No Diagnostic Substances) · US
- HQ
- ALAMEDA, CA
- Industry
- Biological Products, (No Diagnostic Substances)
- Country
- US
In the news · 2
Scribe Therapeutics stock coverage initiated at Goldman Sachs
1 source
·3h ago
More in Healthcare